abstract |
The present invention relates to the concomitant administration of ACAT and MMP inhibitors to reduce macrophage and smooth muscle cell components of atherosclerotic lesions, thereby alleviating the expansion of existing lesions and progression of new lesions, And promotes degeneration of the lesion. |